Surgical gloves create a protective barrier, however high perforation rates (6 percent to 60 percent) are reported in the literature. A recent study has suggested linkage between glove perforation and increased risk of surgical site infection (SSI). Researchers at the Medical College of Wisconsin and from the Ernst Moritz Amdt University in Greifswald, Germany evaluated a model of microbial passage through conventional single (A), double-thickness (B) and a tri-layer innovative surgical glove (C) with antimicrobial activity.
Bacterial passage was assessed following multiple glove puncture using S. aureus and B. (Pseudomonas) diminuta (BD) in a model of gross wound contamination in volunteers in Groups A, B and C. Using microbiological methods bacterial passage was assessed at 5-, 10-, 30- and 45-minute exposure, expressed as cfu per unit time. A total of  six repetitions were made for each glove/time interval. The Mann Whitney test was used to assess the differences in microbial passage between the three groups.
Microbial passage was evaluated separately (5, 10, 30 and 45 minutes) and combined (5/10 and 30/45). No significant differences were observed in microbial passage between Groups A and B at 10, 30, or 45 minutes, a significant difference was observed in Group C at 5, 30 and 45 minutes compared to A and B for SA and BD. When timed groups were combine a significant reduction in passage of SA and BD was observed compared to Groups A and B.
Edmiston, et al. concluded that an antimicrobial surgical glove was effective at reducing microbial passage (p<0.05-p<0.005) following glove perforation compared to single or double-layer gloves. They add that these findings suggest further studies are warranted to assess the clinical efficacy of an innovative antimicrobial glove technology as a SSI risk-reduction strategy. Their research was presented at the International Conference on Prevention & Infection Control (ICPIC) held in Geneva, Switzerland June 29-July 2, 2011.
Reference: CE Edmiston, CJ Krepel, BD Lewis, KR Brown, PJ Rossi, GR Seabrook and G Daeschlein. Using innovative antimicrobial glove technology to reduce the risk of surgical wound contamination following glove perforation. Presentation at International Conference on Prevention & Infection Control (ICPIC). BMC Proceedings 2011, 5(Suppl 6):O33
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.